You are here: Industry Insights > CRISPR

News List

Gene-targeted cancer drugs, slow release overcome resistance worldpharmanews
September 17, 2019
Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and ...
Scientists Use Gene-Editing Tool CRISPR in Attempt to Cure HIV drugs
September 16, 2019
The first attempt to use the gene-editing tool CRISPR to cure HIV infection was unsuccessful but the approach does show promise.
Trial Tests CRISPR Gene-Editing to Treat Sickle Cell Disease drugs
August 01, 2019
A U.S. clinical trial of CRISPR gene-editing to treat people with sickle cell disease is underway.
First U.S. Trial Using CRISPR Within the Body Set to Begin drugs
July 26, 2019
In a U.S. first, a clinical trial to begin this fall will use the inside-the-body gene-editing technique CRISPR to try to cure illness.
MilliporeSigma, Broad Institute Announce CRISPR License Framework contractpharma
July 19, 2019
New framework aims to simplify and accelerate access to CRISPR IP for research.
GSK and University of California team up on CRISPR research pharmaceutical-technology
June 19, 2019
UK-based GlaxoSmithKline (GSK) has partnered with the University of California to carry out genomic research for drug discovery applications.
Study shows CRISPR could help treat lung disease in utero pharmaceutical-technology
April 22, 2019
Study shows CRISPR could help treat lung disease in utero.
Researchers use gene editing with CRISPR to treat lethal lung diseases before birth firstwordpharma
April 21, 2019
Researchers writing in Science Translational Medicine say they used CRISPR gene editing to thwart a lethal lung disease in an animal model in which a harmful mutation causes death within hours after birth, reported ScienceDaily.
A better CRISPR? RNA 'hairpins' could improve gene editing fiercebiotech
April 17, 2019
One of the biggest worries holding back the burgeoning field of CRISPR gene editing is that the technology can make mistakes, causing off-target effects by cutting the wrong piece of DNA.
EdiGene raises $15 M in Series B funding biospectrumasia
April 11, 2019
EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for the treatment of genetic ……

Previous page 1 2 3 4 5 6 7 8 Next page